
In this episode, Gerry speaks with Michael Seen, clinical coordinator and researcher, about the troubling intersection of metabolic disease and cancer disparities.
They explore how metabolic dysfunction fuels cancer aggression, the societal and environmental roots of the obesity epidemic, and the compex role of the infamous "wonder drug" Ozempic.
The conversation also touches on the challenges of public health communication and its important role in rebuilding trust in an age of rampant misinformation and skepticism towards science.
Despite the sobering realities, Michael shares a hopeful vision for rebuilding public trust. If experts are willing to step out of the lab and meet people where they are, true progress can be made.
//
JOIN THE COMMUNITY
SUBSTACK - NEVER MISS NEW RELEASES - SIGN UP TO OUR MAILING LIST
INSTAGRAM // FACEBOOK // THREADS
STAY SAFE
//